Search | VHL Regional Portal

Would your patient benefit from a monoclonal antibody?

Campbell, Levi S; Sbar, Evelyn D.

J Fam Pract ; 71(8): E1-E8, 2022 10.

Article in English | MEDLINE | ID: mdl-36508563

ABSTRACT

These unique agents may be the answer when other treatments fail or are intolerable for patients with asthma, atopic dermatitis, hyperlipidemia, osteoporosis, or migraine headaches.

Subject(s)

Asthma , Dermatitis, Atopic , Migraine Disorders , Humans , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Dermatitis, Atopic/drug therapy , Asthma/drug therapy , Migraine Disorders/drug therapy

See more details

SEND TO:

Export

RSS

XML

SELECTION OF CITATIONS

List items (0)
Clear list

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL